Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).
The UK is set to train many more highly skilled engineers in prosthetics and orthotics following the announcement of a new global centre of excellence based at the University of Salford.
Michael Roth, Research Group Leader at University Hospital Basel asks if disturbed cell-cell interaction causes asthma and provides a fascinating response.
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Henry Jones spoke to Nishat from Open Access Government about mental health platform Big White Wall (BWW), in light of expected UK Government White Paper on Online Harms.
Around 1 in 15 people affected by Tuberculosis (TB) are likely to get the treatable fungal infection Aspergillosis, according to TB research by The University of Manchester and Gulu Referral Hospital, Uganda.
We all know that a woman’s fertility decreases as she gets older, and the quality and number of her eggs decline: why is there a ten-year limit on egg freezing?
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
Professor John Wilding from the University of Liverpool discusses how more effective use of treatments and greater support for healthcare professionals can make the difference in the battle against Type 2 diabetes
Heinz Zwierzina M.D., CDDF Managing Director tells us all about biomarkers and patients’ access to personalised oncology drugs in Europe in this insightful article
Patients could benefit from faster access to treatment under 2 new programmes. The programmes will identify treatment and new technology then speed up their uptake across the NHS
Professor Giles Vassal, President of the European Society for Paediatric Oncology outlines why it is crucial for Europe to come together and tackle and prevent...
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders
